key: cord-0859486-br88sp8b authors: Öncü, I.N.S.; Güler, D.; Gürel, G.; Yalçın, G.Ş. title: Pityriasis Rosea in a Confirmed COVID-19 Pediatric Patient() date: 2021-07-14 journal: Actas Dermosifiliogr DOI: 10.1016/j.adengl.2021.07.006 sha: 59c0e8986ac13d701ae374b6367c70d32d76f764 doc_id: 859486 cord_uid: br88sp8b nan Autor para correspondencia: Işın Nur Sultan Öncü reported. Among these, Pityriasis rosea (PR) and PR-like rash have been published previously. During the COVID-19 pandemic, the diagnosis of PR has become more common. 1, 2, 3, 4, 5 PR is a self-limited inflammatory skin disease that can be induced viral agents especially HHV-6 (Human herpes virus 6), HHV-7 (Human herpes virus 7), autoimmunity, psychogenic factors, vaccines and drugs. 1, 2 We present here a case of PR in a a confirmed COVID-19 pediatric patient A 10-year-old boy presented with a 20-day history of skin rash. It was learned that he had The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease Pityriasis rosea-like eruption revealing COVID Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19 Pityriasis rosea and COVID-19 Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: A report of 2 cases